AOD-9604 Research for Obesity
An evidence-based overview of research examining AOD-9604 in the context of obesity. This page synthesizes findings from peer-reviewed literature.
Research Summary
AOD-9604 was developed specifically for obesity treatment. Early phase trials showed promising signals, but the pivotal Phase 2b/3 OPTIONS study with 536 subjects failed to demonstrate statistically significant weight loss compared to placebo. Development was discontinued in 2007.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Obesity
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. AOD-9604 has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.